UNSPSC 51283718: Cefonicid monosodium

This classification denotes a cephalosporin antibiotic C18H17N6O8S3.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier QD9G66C5UF, chemically known as (6r,7r)-7-((r)-mandelamido)-8-oxo-3-(((1-(sulfomethyl)-1h-tetrazol-5-yl)thio)methyl)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, s-sodium salt, but more generally known as cefonicid monosodium, which bears US NIH Compound Identifier 6336979. Most nations, for tariff and trade purposes, schedule cefonicid monosodium under HS 29419000 and SITC 54139.

As of Q4 2014, CEFONICID MONOSODIUM remains US FDA's Preferred Term for this commodity. Cefonicid monosodium bears US NLM identifiers UMLS ID CL386475 and NCI Concept Code C76170. SMILES: C1CCC(CC1)[C@H](C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)CSC4NNNN4CS(=O)(=O)[O-])C(=O)O)O.[NA+].

UNSPSC 51283718 Cefonicid monosodium is a Commodity code that captures pharmaceutical active ingredients and finished pharmaceutical products procured by state and local health departments and county health systems. Recent state and local solicitations under this code show purchasing of specific antibiotic and emergency-response pharmaceutical products — state health departments sourcing bulk pharmaceutical inventory through cooperative purchasing agreements, and county health authorities acquiring naloxone and drug deactivation systems for community health and overdose-response programs. The issuing bodies are primarily state health departments and county government health divisions, with purchases often structured through cooperative purchasing consortiums like MMCAP to leverage volume pricing and standardized procurement terms.

The code shows recent activity across Florida and Illinois. The Illinois Department of Public Health awarded a piggyback pharmaceutical contract through the MMCAP Infuse consortium to Chartwell Rx LLC on August 28, 2026 (Bid Number 26-482DPH-PREPD-B-53392, completed award totaling $2.99 million over 12 months with renewal options for years 2 and 3) for Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets under an IFB process. Seminole County, Florida released IFB 60459723LAS on June 30, 2026, seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, with a response deadline of July 26, 2023. State and local buyers in this code operate through both direct procurement and piggyback arrangements on existing cooperative contracts, and purchases typically include fixed-fee pricing with multi-year renewal options.